Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072682 · ClinicalTrials.gov registry record · NA
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
A NA study, sponsored by SeaStar Medical.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT01072682: Completed NA study, sponsored by SeaStar Medical.
NCT01072682 is a NA study that has completed, run by SeaStar Medical. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01072682, a NA study, has completed, sponsored by SeaStar Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this protocol is to evaluate the safety of a selective cytopheretic device (SCD) in patients that are on continuous renal replacement therapy (CRRT) for acute renal failure (ARF).
Interventions
- DEVICE Selective cytopheretic device (SCD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT01072682 record still lists
NCT01072682 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Selective cytopheretic device (SCD) is the first listed.
NCT01072682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01072682 about?
NCT01072682 is a clinical study titled "Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure". The purpose of this protocol is to evaluate the safety of a selective cytopheretic device (SCD) in patients that are on continuous renal replacement therapy (CRRT) for acute renal failure (ARF).
What is the current status of trial NCT01072682?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2010-02. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01072682?
The interventions under investigation include: Selective cytopheretic device (SCD) (DEVICE).
Who is sponsoring clinical trial NCT01072682?
This trial is sponsored by SeaStar Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01072682's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia